Minerva Capital Research Solutions

Dabur India

NSE: DABURBSE: 500096
Compare with peers
₹ 360.00▲ 2.2 (+0.61%)28 Oct, 03:28 pm IST
P/E
32.5x
52-week range
354.3 – 534
ROE
17%
ROCE
20%
Sector
Personal Products
Industry
Personal Care
Listed on
NSE, BSE

About

Dabur India Limited is a fast-moving consumer goods (FMCG) company. Its segments include Consumer care business, Food business, and Other segments. Its Consumer care business segment includes home care, personal care, and health care. Its Food business segment includes juices, beverages, and culinary. Its Other segments include Guar gum, pharma and others. Its product categories include hair care, oral care, health care, skin care, home care, energizers, cold and cough, digestives, and ethicals. Its health supplements portfolio includes Dabur Chyawanprash, Dabur Honey, Dabur Giloy Neem Juice with Tulsi, and others. Its oral care portfolio includes Dabur Red Paste, Dabur Meswak, Dabur Babool, and Dabur Herb'l. Its foods portfolio includes Real Fruit Power Juices, Real Activ 100% Juices, Hommade, and Real Milkshakes. Its skin care portfolio includes Fem, Oxylife, and Gulabari. Its ethicals portfolio includes Ashokarishta, Dashmularishta, Lavanbhaskar Churna, and Dabur Shwaasamrit.

Quick check

The five things to look at first. Open one for more.

Compared with its industry

Personal Care: 22 companies →

Dabur India against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.

  • Valuation (P/E)32.5 against a typical 33.9: cheaper than most peers (1st = cheapest).11th of 22
  • Sales growth+10.5% against a typical +14.9% from a year earlier.11th of 15
  • Profit growth+15.4% against a typical +8.9% from a year earlier.5th of 13
  • Share price, 3 months−17.5% against a typical −6.6%.14th of 19

Credit ratings

Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates

Highest safety

Rated AAA by 2 agencies
AAA
DefaultRiskyModerateSafeVery safe
  • All agencies agree and none has raised a warning.
AgencyCurrent ratingOutlookAs of
ICRA[ICRA]AAA /[ICRA]A1+Stable12 Mar 2026
CRISILCrisil AAAStable20 Nov 2025
Credit rating actions
RatingDetails
12 Mar 2026
Reaffirmed
[ICRA]AAA /[ICRA]A1+—ICRA₹ 1,425 Cr.
20 Nov 2025
Reaffirmed
Crisil AAA—CRISIL₹ 368.5 Cr.

Board meetings

Results dates and other board meetings. Full calendar

Details
4 Nov 2026UpcomingFinancial Results/DividendTo consider and approve the unaudited financial results for the quarter and half year ending on September 30, 2026 and Interim dividend for the Financial Year 2026-27
29 Jul 2026Financial ResultsTo consider and approve the unaudited financial results for the period ended Jun 30, 2026
7 May 2026Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2026 and dividend
29 Jan 2026Financial ResultsTo consider and approve the unaudited financial results for the quarter/nine months ending on December 31, 2025
30 Oct 2025Financial Results/DividendTo consider and approve the financial results for the quarter and half year ended September 30, 2025 and interim dividend
31 Jul 2025Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2025
7 May 2025Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2025 and dividend

Share price

1Y change −29%
Volume (shares)Price (₹)
Close price

Financials

Consolidated figures in ₹ crore.

Quarterly results
₹ Cr.Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales3,2043,2552,8153,3493,0293,3552,8303,4053,1913,5593,0383,764
Expenses2,5432,5882,3482,6942,4762,6732,4032,7372,6032,8252,5773,024
Operating Profit661667466655553682427667588734461741
OPM %21%20%17%20%18%20%15%20%18%21%15%20%
Other Income117127129129152129141144140126175173
Interest283635334744393540314037
Depreciation9897107109111109117114115117122121
Profit before tax651661453642546658412663573711474756
Tax %22%23%25%23%24%22%24%23%22%22%24%22%
Net Profit507506341494418516313508445554362586
EPS in Rs2.912.91.972.822.42.951.812.92.553.162.083.33

Growth and returns

Compounded yearly rates over each period.

Compounded Sales Growth
10 Years
5%
5 Years
7%
3 Years
5%
TTM
7%
Compounded Profit Growth
10 Years
4%
5 Years
2%
3 Years
4%
TTM
11%
Stock Price CAGR
10 Years
3%
5 Years
−8%
3 Years
−11%
TTM
—
Return on Equity
10 Years
21%
5 Years
19%
3 Years
18%
TTM
—

Shareholding

Latest: Jun 2026.

Promoters
66.24%
+0.02 pts in a year
FIIs
9.66%
−2.19 pts in a year
DIIs
18.6%
+2.44 pts in a year
Government
0.12%
+0.05 pts in a year
Public
5.37%
−0.32 pts in a year

P/E and EPS over time

Daily P/E and trailing 12-month EPS. EPS updates with each result.

P/E 32.5xEPS (12 months) ₹ 11.18Median P/E 41.5x
P/E (times)EPS (₹)

Peers

Listed companies in the same business.

Peer comparison
Dabur India₹ 360.00—32.5x—17%—
Hindustan Unilever₹ 1,820.00₹ 4,27,626 Cr.48.3x10.3x21.5%16.1%
Godrej Consumer Products₹ 851.50₹ 87,134 Cr.54.2x8.7x15.1%12.3%
Marico₹ 764.10₹ 99,347 Cr.62.2x26x43.1%13.3%
Cupid₹ 306.50₹ 41,214 Cr.271.9x64.1x27.3%30.3%
Gillette India₹ 7,222.60₹ 23,535 Cr.38.9x26.9x66.4%21.1%

Management

Mohit Malhotra
Global Chief Executive Officer, Whole Time Director
Ankush Jain
Chief Financial Officer, Joint Chief Risk Officer
Ashok Kumar Jain
Group Company Secretary and Chief Compliance Officer
Pritam Das Narang
Group Director - Corporate Affairs, Whole-Time Director
Abhinav Dhall
Head - Group Corporate Strategy
Saurabhkumar Narendra Lal
Head of Operations
Saket Gupta
Joint Company Secretary

Prices are delayed and for information only. Nothing on this page is investment advice.